Evaluating Patient Preferences for the Treatment of Localized Prostate Cancer - A Discrete Choice Experiment.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Antineoplastics
- Indications Prostate cancer
- Focus Therapeutic Use
- Acronyms COMPARE
Most Recent Events
- 18 Dec 2013 Accrual to date is 9% according to United Kingdom Clinical Research Network.
- 13 Nov 2013 Accrual to date is 4% according to United Kingdom Clinical Research Network.
- 17 Oct 2013 Accrual to date is 2% according to United Kingdom Clinical Research Network.